Sarah is an articling student in our Toronto office. She completed her Juris Doctor at the University of Toronto.
Sarah graduated summa cum laude with an Honours Bachelor of Science from the University of Ottawa, earning the University Silver Medal in her program. She consistently received Merit Scholarships (2013-2015) and made the Dean's Honours List (2012-2016).
While completing her Ph.D., Sarah investigated the impact of a collagen biomaterial on heart function post-heart attack in a mouse model. Her research, funded by Canada Graduate Scholarships, earned the best science poster at the Ottawa Cardiovascular Research Day (2021), and the results of the project were published in two peer-reviewed journals.
During her legal studies, Sarah held a Gerald W. Schwartz Summer Fellowship (2022), where she conducted research under Professor Trudo Lemmens on legislative responses to the Long-term Care COVID-19 Commission Report. She also competed in the 2023 Harold G. Fox Moot where her mooting team advanced to the finals and achieved runner-up status.
Sarah’s passion for Intellectual Property law began during her Ph.D. when the biomaterial she studied was part of a patent application. Participation in the Harold G. Fox Moot and working as a summer student at an IP law firm deepened her interest in the field. She looks forward to joining Smart & Biggar as an articling student, eager to learn from leading IP practitioners and acquire experience across a variety of practices in the field of intellectual property.
Qualifications
- News
- In the Media
Publications
- McLaughlin S et.al. Recombinant Human Collagen Hydrogel Rapidly Reduces Methylglyoxal Adducts within Cardiomyocytes and Improves Borderzone Contractility after Myocardial Infarction in Mice. Advanced Functional Materials. August 2022. 32;32 (https://doi.org/10.1002/adfm.202204076)
- McLaughlin S et.al. Characterization of the monocyte response to biomaterial therapy for cardiac repair. Methods in Molecular Biology. 2022. 2485: 279-298 (https://pubmed.ncbi.nlm.nih.gov/35618913/)
- McLaughlin S and McNeill B, et.al. Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction. Nature Communications. October 2019. 10: 4866 (https://www.nature.com/articles/s41467-019-12748-8)